Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nijsten

Showing results (11-20 of 701) with videos related to

Pageof 71
Sort By:
The British Journal of Dermatology|April 19, 2017
The four Ws of skin cancer surveillance in patients with melanoma: Why? Who? When? Where?T Nijsten, M Wakkee
The British Journal of Dermatology|May 22, 2016
Actinic keratosis in China: big numbers and small percentagesM Wakkee, T Nijsten
Journal of the European Academy of Dermatology and Venereology : JEADV|February 6, 2021
Outcome assessment in dermatology: a tree in need of pruningA Ragamin, T Nijsten
Nederlands Tijdschrift Voor Geneeskunde|May 13, 2020
[Incidence of melanoma among young people: likely to be lower than reported]Tamar Nijsten, Loes Hollestein
Dermatology (Basel, Switzerland)|September 24, 2008
Psocare: Italy shows the way in postmarketing studiesTamar Nijsten, Marlies Wakkee
The Journal of Investigative Dermatology|June 13, 2009
Complexity of the association between psoriasis and comorbiditiesTamar Nijsten, Marlies Wakkee
Nederlands Tijdschrift Voor Geneeskunde|February 17, 2018
[Regained freedom for patients with atopic dermatitis; fast and long-term effects of dupilumab]T Nijsten, D J Hijnen
Pigment Cell & Melanoma Research|November 2, 2016
Commentary on: "A genome-wide association study in Caucasian women suggests the involvement of HLA genes in the severity of facial solar lentigines" by Laville et al., 2016Leonie C Jacobs, Tamar Nijsten
The British Journal of Dermatology|April 17, 2014
The association between beta-blockers and melanoma survival: evidence of absence or absence of evidence?L M Hollestein, T Nijsten
The British Journal of Dermatology|August 24, 2017
Keratinocyte skin cancers in the spotlightT Nijsten, I M Leigh
Pageof 71

Showing results (11-20 of 701) with videos related to

Sort By:
Pageof 71
The British Journal of Dermatology|April 19, 2017
The four Ws of skin cancer surveillance in patients with melanoma: Why? Who? When? Where?T Nijsten, M Wakkee
The British Journal of Dermatology|May 22, 2016
Actinic keratosis in China: big numbers and small percentagesM Wakkee, T Nijsten
Journal of the European Academy of Dermatology and Venereology : JEADV|February 6, 2021
Outcome assessment in dermatology: a tree in need of pruningA Ragamin, T Nijsten
Nederlands Tijdschrift Voor Geneeskunde|May 13, 2020
[Incidence of melanoma among young people: likely to be lower than reported]Tamar Nijsten, Loes Hollestein
Dermatology (Basel, Switzerland)|September 24, 2008
Psocare: Italy shows the way in postmarketing studiesTamar Nijsten, Marlies Wakkee
The Journal of Investigative Dermatology|June 13, 2009
Complexity of the association between psoriasis and comorbiditiesTamar Nijsten, Marlies Wakkee
Nederlands Tijdschrift Voor Geneeskunde|February 17, 2018
[Regained freedom for patients with atopic dermatitis; fast and long-term effects of dupilumab]T Nijsten, D J Hijnen
Pigment Cell & Melanoma Research|November 2, 2016
Commentary on: "A genome-wide association study in Caucasian women suggests the involvement of HLA genes in the severity of facial solar lentigines" by Laville et al., 2016Leonie C Jacobs, Tamar Nijsten
The British Journal of Dermatology|April 17, 2014
The association between beta-blockers and melanoma survival: evidence of absence or absence of evidence?L M Hollestein, T Nijsten
The British Journal of Dermatology|August 24, 2017
Keratinocyte skin cancers in the spotlightT Nijsten, I M Leigh
Pageof 71